Glasgow
Professor Kevin Blyth
Director and Founder of the Scottish Mesothelioma Network
Professor Kevin Blyth is a Consultant Respiratory Physician and Clinical Academic based at the Queen Elizabeth University Hospital and the Institute of Cancer Sciences/Beatson Institute at the University of Glasgow. He leads the Glasgow Pleural Disease Unit, which delivers diagnostic and therapeutic services, including thoracoscopy, and a range of clinical trials.
He founded and is Director of the Macmillan Scottish Mesothelioma Network, which coordinates clinical care and access to trials for all patients in Scotland. He is an NHS Scotland Research (NRS) Senior Research Fellow and leads a translational research program focused on pleural disease and thoracic malignancy and has a particular interest in Mesothelioma. He is Principal Investigator of the CRUK PREDICT-Meso International Accelerator Network.
Dr Selina Tsim
Dr. Selina Tsim is a Macmillan Consultant Respiratory Physician based at the Queen Elizabeth University Hospital and an Honorary Clinical Senior Lecturer at the Institute of Cancer Sciences, University of Glasgow.
She has a specialist interest in mesothelioma, lung cancer and pleural disease and is one of the Mesothelioma Lead Clinicians for the West of Scotland, providing a specialist pleural service, including thoracoscopy and indwelling pleural catheter insertion, and co-chairing the Scottish Mesothelioma MDT.
Dr. Tsim was awarded a PhD from the University of Glasgow in 2018 and was one of the co-authors of the British Thoracic Society guideline on the Investigation and Management of Mesothelioma.
Edinburgh
Dr Phil Reid
Dr. Phil Reid is a respiratory consultant based at Edinburgh’s Western General Hospital where he is also clinical lead of the department. He is the Mesothelioma Lead Clinician for South East Scotland within the Scottish Mesothelioma network. His specialist interests include lung cancer, pleural disease alongside teaching and training.
Dundee
Dr Phil Short
Dr Short is a Consultant Respiratory Physician based at Ninewells Hospital in Dundee. Dr Short is lead for the pleural service in NHS Tayside which provides medical thoracoscopy and indwelling pleural catheter insertion. Dr Short is Mesothelioma Lead Clinician for NHS Tayside.
Graduating from the University of Dundee in 2004, Dr Short undertook training in Respiratory Medicine in Tayside and Lothian. He was awarded a MD from the University of Dundee in 2014 and was appointed as a Consultant in 2015.
Aberdeen
Dr Mahendran Chetty
Dr. Chetty is a Consultant Respiratory Physician with a special interest in pleural diseases and lung cancer. He is based in Aberdeen Royal Infirmary (NHS Grampian) and leads Pleural service in Aberdeen Royal Infirmary which offers diagnostic and therapeutic pleural interventions including thoracic Ultrasound and indwelling pleural catheter insertion.
He is a part of Scottish Mesothelioma Network and Mesothelioma Lead Clinician for NHS Grampian.
INVERNESS
Dr Carol MacGregor
Dr Carol MacGregor is a Macmillan Consultant Clinical Oncologist with a special interest in Mesothelioma and Lung cancer based at Raigmore Hospital in Inverness. She specialises in the use of radiotherapy and systemic anti cancer therapy such as chemotherapy and immunotherapy. She is also Service Clinical Director for the Department of Clinical Oncology which provides non surgical oncology treatments to patients in NHS Highland and NHS Western Isles.
She is part of the Scottish Mesothelioma Network and is Mesothelioma Lead Clinician for NHS Highland and NHS Western Isles.
Dr Beth Sage
Dr Beth Sage is a Consultant Respiratory physician at Raigmore Hospital, Inverness and Honorary Senior Lecturer at the University of Aberdeen. She has a specialist interest in mesothelioma, lung cancer and pleural disease. She won a Medical Research Council Fellowship to complete a PhD in novel therapies for malignant mesothelioma at UCL which she completed in 2013. Beth is clinical lead for lung cancer and has a research interest in early diagnosis of thoracic malignancies and improving access to cancer services in remote and rural populations. She is Director of Research, Development and Innovation at NHS Highland and a Co-Investigator on clinical trials looking at genetically modified cell therapies in thoracic malignancies. She is part of the Scottish Mesothelioma Network, the North Cancer Alliance Lung Pathway Board, is on the Scientific Research Committee for the British Lung Foundation and an Associate Editor for Thorax.